HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
41.24
+0.07 (+0.17%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close41.17
Open41.38
Bid40.00 x 1800
Ask43.13 x 36900
Day's Range41.16 - 41.38
52 Week Range35.10 - 45.09
Volume1,880,123
Avg. Volume2,086,622
Market Cap11.222B
Beta0.83
PE Ratio (TTM)N/A
EPS (TTM)-0.29
Earnings DateNov 6, 2018 - Nov 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est44.73
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding HOLX is favorable, with net inflows of $27.64 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

  • Cynosure Headwinds Trigger Analyst Downgrades on HOLX Stock
    Market Realist4 days ago

    Cynosure Headwinds Trigger Analyst Downgrades on HOLX Stock

    Hologic (HOLX) is a medical technology company focused on women’s health with headquarters in Marlborough, Massachusetts. The company offers solutions across four segments including diagnostics, breast and skeletal health, gynecological surgery, and medical aesthetics. The company recently provided an update on the financial impact of its recently announced marketing and distribution suspension of its TempSure Vitalia handpiece and probes. We discussed the details in the previous article of this series. ...

  • Hologic’s Cynosure Headwinds Could Impact 2018 Earnings
    Market Realist4 days ago

    Hologic’s Cynosure Headwinds Could Impact 2018 Earnings

    On September 12, Hologic (HOLX) provided an update on the financial impact of the suspension of its marketing and distribution of the company’s Vitalia handpieces and probes, which it announced in August. The company issued form 8-k on August 13 reporting its decision to suspend the marketing and distribution of the company’s Tempsure Vitalia handpieces and probes. The device, part of the company’s Cynosure division, was recalled on FDA (U.S. Food and Drug Administration) concerns around this class of products, which are used for vaginal rejuvenation procedures. The FDA sent letters to certain companies that manufactured these kinds of devices.

  • A Look at Hologic Stock’s Recent Performance
    Market Realist4 days ago

    A Look at Hologic Stock’s Recent Performance

    On September 17, Hologic (HOLX) ended the day at $39.53. The stock was down ~0.3% from its previous trading day’s closing price of $39.64. The stock has recuperated some of the losses it saw during the first half of fiscal 2018. It witnessed a declining trend after reporting its 52-week high of $45.09 on January 9, 2018.

  • GlobeNewswire9 days ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Hologic, Inc.

    NEW YORK, Sept. 13, 2018-- Levi & Korsinsky announces it has commenced an investigation of Hologic, Inc. concerning possible violations of federal securities laws. Hologic is the parent company of Cynosure, ...

  • Benzinga9 days ago

    Hologic Downgraded By BofA As Cynosure Headwinds Persist

    An 8-K filed late Wednesday suggests Hologic, Inc. (NASDAQ: HOLX )’s headed for harder times . The Analyst Bank of America Merrill Lynch analyst  Derik de Bruin downgraded Hologic from Buy to Neutral and ...

  • Insulet names its female president as next CEO
    American City Business Journals12 days ago

    Insulet names its female president as next CEO

    Billerica-based Insulet Corp. has announced that its president and chief operating officer, Shacey Petrovic, will take over as CEO next year, becoming the state’s largest company by market cap to be headed by a woman.

  • What Teleflex’s Valuation Trend Indicates
    Market Realist13 days ago

    What Teleflex’s Valuation Trend Indicates

    From January 2–28, 2018, Teleflex (TFX) stock rose from $254.73 to $287.65, which was its high point so far in 2018. During the broader market turmoil in February, it dipped to a low of $242.67 on March 1. Then it made a steady recovery to $280 in June but has corrected again to its current level of $248.

  • How Hologic’s Valuation Stacks Up with Peers
    Market Realist15 days ago

    How Hologic’s Valuation Stacks Up with Peers

    Hologic is a medical technology firm focused on developing solutions for women’s health. Year-to-date, Hologic stock is down ~9.6%. The event led to a ~4% decline in its stock price on August 13, when the announcement was made.

  • Hologic Stock Down ~9% Year-to-Date
    Market Realist15 days ago

    Hologic Stock Down ~9% Year-to-Date

    On September 6, Hologic (HOLX) ended the day at $38.74. The stock was marginally down from its previous day’s closing price of $39.04. Hologic stock hit a 52-week high of $45.09 at the start of this year, on January 9, 2018.

  • Analysts Still Bullish on Teleflex Stock
    Market Realist15 days ago

    Analysts Still Bullish on Teleflex Stock

    Teleflex’s (TFX) interest expenses increased from $19.89 million in the second quarter of 2017 to $26.65 million in the second quarter of 2018. Its income taxes, on the other hand, decreased from $12.1 million in the second quarter of 2017 to $9.58 million in the second quarter of 2018.

  • Understanding Teleflex’s Operational Performance
    Market Realist15 days ago

    Understanding Teleflex’s Operational Performance

    Teleflex’s (TFX) geographic segments include the United States, Europe, Asia, and other. Teleflex incurred a total cost of sales of $265.09 million in the second quarter of 2018 compared to $238.3 million in the second quarter of 2017. For fiscal 2018, Teleflex’s gross margins are expected to be 57.56% compared to 55.76% for fiscal 2017.

  • Analysts Project ~16.5% Upside in Hologic Stock
    Market Realist15 days ago

    Analysts Project ~16.5% Upside in Hologic Stock

    Hologic (HOLX) is a medical technology firm focused on improving women’s health. The company operates across four segments: diagnostics, GYN surgical, breast cancer, and skeletal health. The company reported strong Q3 2018 earnings results, which led to a rise in its stock price. In this article, let’s look at analysts’ recommendations for HOLX stock.

  • PR Newswire16 days ago

    Hologic to Webcast Presentation at the Morgan Stanley 16th Annual Global Healthcare Conference

    MARLBOROUGH, Mass. , Sept. 6, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 16 th Annual Global Healthcare Conference in New York, ...

  • Hologic (HOLX) Down 4.8% Since Last Earnings Report: Can It Rebound?
    Zacks23 days ago

    Hologic (HOLX) Down 4.8% Since Last Earnings Report: Can It Rebound?

    Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • How Is Roche’s Diagnostics Segments Positioned in August?
    Market Realist29 days ago

    How Is Roche’s Diagnostics Segments Positioned in August?

    In Roche’s Diagnostics division, the Centralized Point of Care Solutions segment reported first-half revenues of 3.76 billion Swiss francs, reflecting ~6.0% YoY growth at CER (constant exchange rates). In the second quarter, Roche’s (RHHBY) Centralized and Point of Care Solutions reported revenues of 2.0 billion Swiss francs, which reflected ~9.0% YoY growth at CER.

  • GlobeNewswirelast month

    Research Report Identifies America's Car-Mart, SAExploration, Ascena Retail Group, Infinity Pharmaceuticals, Hologic, and California Resources with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, Aug. 22, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of America's ...

  • PR Newswirelast month

    Final USPSTF Cervical Cancer Screening Recommendations Retain "A" Grade for Pap + HPV for Women Ages 30 to 65

    MARLBOROUGH, Mass. , Aug. 21, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX), a pioneer in cervical cancer screening, commends the United States Preventive Services Task Force (USPSTF) for retaining ...

  • GlobeNewswirelast month

    INVESTIGATION UPDATE for DY, HOLX and LOGM: Levi & Korsinsky, LLP Reminds Investors of Investigations on Behalf of Shareholders

    Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Levi & Korsinsky announces it has commenced an investigation of Dycom Industries, Inc. (“Dycom” or “the Company”) (DY) concerning possible violations of federal securities laws. On August 13, 2018, Dycom announced disappointing results for the quarter ended July 28, 2018, and announced it would revise its financial guidance for fiscal 2019.

  • Hologic Launches Fluent Fluid Management System, Widens Suite
    Zackslast month

    Hologic Launches Fluent Fluid Management System, Widens Suite

    Hologic (HOLX) adopts initiatives to boost the GYN Surgical segment.

  • Hologic Launches Fluent™ Fluid Management System for Hysteroscopic Procedures
    PR Newswirelast month

    Hologic Launches Fluent™ Fluid Management System for Hysteroscopic Procedures

    MARLBOROUGH, Mass., Aug. 16, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today the U.S. launch of its new Fluent™ fluid management system, featuring innovations designed to provide operating room (OR) staff more simplified and effective fluid management for hysteroscopic procedures. "Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology," said Edward Evantash, M.D., Medical Director and Vice President of Global Medical Affairs, Hologic. "The Fluent system is changing the game in fluid management.

  • PR Newswirelast month

    Hologic's Cynosure Division Signs Agreement with Porter Instrument to Exclusively Distribute Nitrous Oxide and Oxygen System in Aesthetics Market

    Cynosure is the first medical aesthetic manufacturer offering enhanced patient experiences powered by Nitronox™ analgesia systems MARLBOROUGH, Mass. , Aug. 15, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: ...

  • 7 Bargain Stocks in Today's Pricey Market
    Kiplingerlast month

    7 Bargain Stocks in Today's Pricey Market

    Investors can rummage through the cheapie bin, looking for stocks with ultralow price-earnings ratios. But buying so-called deep value stocks isn't for the faint of heart: Their shares tend to be inexpensive because of a downturn in their business, and they may not rebound soon. Yet bargain hunters aren't entirely out of luck. Banks and other financial firms, for instance, trade at an average 36% discount to Standard & Poor's 500-stock index, based on the stocks' book value (assets minus liabilities), according to Bank of America Merrill Lynch. Some media companies also look inexpensive, along with technology firms that aren't as pricey as the stars of the tech world but still have strong prospects. The following seven stocks are bargains you can bet on for the long term. Our picks are profitable and leaders in their fields, but their shares trade at reasonable prices because of pressures in their industry or company-specific challenges. Eventually, we think those issues will subside. And for now, investors can buy these stocks at an attractive discount to the broad market or to industry averages. That should help set up strong returns, even if the stocks' prices rise only enough to get back to long-term average valuations. SEE ALSO: The 10 Best Stocks for GOP Tax Reform

  • GlobeNewswirelast month

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Hologic, Inc.

    NEW YORK, Aug. 14, 2018-- Levi & Korsinsky announces it has commenced an investigation of Hologic, Inc. concerning possible violations of federal securities laws. Hologic is the parent company of Cynosure, ...

  • NYSE trader: I like tech stocks like Apple and Amazon that are household names
    Yahoo Finance Videolast month

    NYSE trader: I like tech stocks like Apple and Amazon that are household names

    Jonathan Corpina of Meridian Equity Partners joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves. Here's the performance of the Nasdaq 100 component stocks as of 2:30 pm ET: MELI Mercadolibre Inc 3.52% NVDA Nvidia Corp 3.11% TTWO Take-Two Interactive Software 2.33% ATVI Activision Blizzard Inc 2.10% NFLX Netflix Inc 1.88% ADBE Adobe Systems 1.48% ADI Analog Devices 1.36% ALGN Align Tech 1.32% BMRN Biomarin Pharmaceutical 1.26% BKNG(HB) Booking Hldgs Inc 1.22% IDXX Idexx Laboratories 1.16% STX(HB) Seagate Tech 1.08% HOLX Hologic Inc 1.05% ADSK Autodesk, Inc 1.01% ILMN Illumina Inc 0.99% WDAY Workday Inc 0.95% MSFT Microsoft Corp 0.88% CHKP Check Point Software Tech 0.81% PYPL PayPal Hldgs Inc 0.80% CTXS Citrix Systems Inc 0.81% ISRG Intuitive Surgical 0.79% TXN Texas Instruments 0.78% AMZN Amazon.com Inc 0.77% MU Micron Tech 0.70% NTES Netease Inc Ads 0.67% GILD Gilead Sciences 0.71% SIRI Sirius XM Hldgs Inc 0.65% SYMC(E) Symantec Corp 0.66% CDNS Cadence Design Systems 0.64% XLNX Xilinx Inc 0.66% CSCO Cisco Systems 0.48% ROST Ross Stores 0.51% KLAC KLA-Tencor Corp 0.49% BIIB Biogen Inc 0.44% SNPS Synopsys Inc 0.49% AMGN Amgen Inc 0.47% HAS Hasbro Inc 0.46% VRTX Vertex Pharmaceuticals 0.44% EBAY eBay Inc 0.43% ALXN Alexion Pharmaceuticals 0.45% CTSH Cognizant Tech Solutions'A' 0.43% GOOG Alphabet Inc Cl C Cap Stock 0.40% FISV Fiserv Inc 0.42% HSIC Henry Schein Inc 0.41% COST Costco Wholesale Corp 0.39% INTU Intuit Inc 0.32% QCOM Qualcomm Inc 0.35% REGN Regeneron Pharmaceuticals 0.30% ESRX Express Scripts Hldg Co 0.30% FB Facebook Inc 0.30% BIDU Baidu Inc 0.25% ADP Automatic Data Proc 0.26% EA Electronic Arts, Inc. 0.28% GOOGL Alphabet Inc Cl A 0.23% CTAS Cintas Corp 0.20% SHPG Shire plc ADS 0.18% VRSK Verisk Analytics Inc 0.14% PAYX Paychex Inc 0.10% FOXA(F) Twenty-First Century Fox Inc A 0.10% MCHP Microchip Tech 0.05% FOX(F) Twenty-First Century Fox Inc B 0.00% AAPL Apple Inc -0.02% SWKS Skyworks Solutions -0.06% FAST Fastenal Co -0.05% ORLY O'Reilly Automotive, Inc. -0.06% ASML ASML Hldg N.V. New York -0.10% VOD Vodafone Grp Plc ADS -0.10% JBHT Hunt(J.B.)Transport -0.05% WYNN Wynn Resorts Ltd -0.22% INCY Incyte Corp -0.23% MXIM Maxim Integrated Prod -0.24% CA CA Inc -0.27% PCAR PACCAR Inc -0.29% CERN Cerner Corp -0.43% CMCSA Comcast Cl A -0.45% MYL Mylan NV -0.48% KHC The Kraft Heinz Company -0.55% XRAY Dentsply Sirona Inc -0.55% CELG Celgene Corp -0.59% LBTYA Liberty Global plc Cl A -0.62% TSLA Tesla Inc -0.59% LRCX Lam Research -0.75% WBA Walgreen Boots Alliance Inc -0.71% MAR Marriott Int'l Cl A -0.84% MDLZ Mondelez Int'l Inc Cl A -0.88% CTRP Ctrip.com Intl Ltd -0.89% CSX CSX Corp -0.99% DISH DISH Network Corp Cl A -1.04% AVGO Broadcom Inc -1.11% LBTYK Liberty Global plc Cl C -1.09% INTC Intel Corp -1.17% QRTEA Qurate Retail Inc -1.17% WDC Western Digital -1.25% MNST Monster Beverage Corporation -1.33% DLTR Dollar Tree Inc -1.37% CHTR Charter Communications Inc -1.37% TMUS T-Mobile US Inc -1.43% JD JD.com Inc -1.40% AMAT Applied Materials -1.58% EXPE(F) Expedia Grp Inc -1.94% SBUX Starbucks Corp -2.24% AAL American Airlines Grp inc -2.38% ULTA Ulta Beauty Inc -3.14%